Botulinum toxin type A + Placebo
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Muscle Spasticity
Conditions
Muscle Spasticity, Cerebrovascular Accident
Trial Timeline
Feb 1, 2003 → Oct 1, 2007
NCT ID
NCT00234546About Botulinum toxin type A + Placebo
Botulinum toxin type A + Placebo is a approved stage product being developed by Ipsen for Muscle Spasticity. The current trial status is completed. This product is registered under clinical trial identifier NCT00234546. Target conditions include Muscle Spasticity, Cerebrovascular Accident.
What happened to similar drugs?
0 of 20 similar drugs in Muscle Spasticity were approved
Approved (0) Terminated (0) Active (20)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (14)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03569098 | Phase 2 | Completed |
| NCT03598777 | Phase 2 | Terminated |
| NCT02493946 | Phase 3 | Completed |
| NCT02353871 | Phase 3 | Completed |
| NCT02321436 | Approved | Completed |
| NCT01753310 | Phase 3 | Completed |
| NCT01249417 | Phase 3 | Completed |
| NCT01357980 | Phase 2 | Completed |
| NCT01249404 | Phase 3 | Completed |
| NCT00578097 | Phase 2 | Terminated |
| NCT00257660 | Phase 3 | Completed |
| NCT00447876 | Phase 2/3 | Completed |
| NCT00216411 | Approved | Completed |
| NCT00234546 | Approved | Completed |
Competing Products
20 competing products in Muscle Spasticity